Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 8Breast Neoplasms 7Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Pancreatic Neoplasms 3Nasopharyngeal Carcinoma 3Uterine Cervical Neoplasms 2Sarcoma 2Neoplasm Metastasis 2Meningioma 2Liver Neoplasms 2HER2-positive Breast Cancer 2Glioma 2Glioblastoma 2Chordoma 2Carcinoma, Hepatocellular 2Carcinoma, Adenoid Cystic 2Brain Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Resectable Lung Non-Small Cell Carcinoma 1Radiation Injuries 1Pituitary Neoplasms 1Oligodendroglioma 1Neurilemmoma 1Nerve Sheath Neoplasms 1

Interventions

Cyclophosphamide 30N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 21Prednisone 20Etoposide 20Vincristine 16Whole-Body Irradiation 15Doxorubicin 15fludarabine phosphate 14Peripheral Blood Stem Cell Transplantation 14romidepsin 13Mycophenolic Acid 12Lenalidomide 12Gemcitabine 12Cyclosporine 10Azacitidine 10Brentuximab Vedotin 9Bortezomib 9Alemtuzumab 8Dexamethasone 7Methotrexate 6Cytarabine 6Busulfan 6Carmustine 5pembrolizumab 4fludarabine 4Vorinostat 4Tacrolimus 4Rituximab 4Melphalan 4Ifosfamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma, T-Cell, Peripheral × Protons × Clear all
NCT00337987 2015-02-27

A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma

Yale University

Phase 2 Completed
49 enrolled 6 charts
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡